192 related articles for article (PubMed ID: 28492874)
1. Peripapillary Retinal Pigment Epithelium Layer Shape Changes From Acetazolamide Treatment in the Idiopathic Intracranial Hypertension Treatment Trial.
Wang JK; Kardon RH; Ledolter J; Sibony PA; Kupersmith MJ; Garvin MK;
Invest Ophthalmol Vis Sci; 2017 May; 58(5):2554-2565. PubMed ID: 28492874
[TBL] [Abstract][Full Text] [Related]
2. Papilledema Outcomes from the Optical Coherence Tomography Substudy of the Idiopathic Intracranial Hypertension Treatment Trial.
;
Ophthalmology; 2015 Sep; 122(9):1939-45.e2. PubMed ID: 26198807
[TBL] [Abstract][Full Text] [Related]
3. The Relationship Between Optic Disc Volume, Area, and Frisén Score in Patients With Idiopathic Intracranial Hypertension.
Sheils CR; Fischer WS; Hollar RA; Blanchard LM; Feldon SE;
Am J Ophthalmol; 2018 Nov; 195():101-109. PubMed ID: 30081012
[TBL] [Abstract][Full Text] [Related]
4. The Effect of Treatment of Idiopathic Intracranial Hypertension on Prevalence of Retinal and Choroidal Folds.
Kupersmith MJ; Sibony PA; Feldon SE; Wang JK; Garvin M; Kardon R;
Am J Ophthalmol; 2017 Apr; 176():77-86. PubMed ID: 28040526
[TBL] [Abstract][Full Text] [Related]
5. Optical coherence tomography of the swollen optic nerve head: deformation of the peripapillary retinal pigment epithelium layer in papilledema.
Kupersmith MJ; Sibony P; Mandel G; Durbin M; Kardon RH
Invest Ophthalmol Vis Sci; 2011 Aug; 52(9):6558-64. PubMed ID: 21705690
[TBL] [Abstract][Full Text] [Related]
6. Optical coherence tomography shape analysis of the peripapillary retinal pigment epithelium layer in presumed optic nerve sheath meningiomas.
Sibony P; Strachovsky M; Honkanen R; Kupersmith MJ
J Neuroophthalmol; 2014 Jun; 34(2):130-6. PubMed ID: 24625774
[TBL] [Abstract][Full Text] [Related]
7. Optic disc haemorrhages at baseline as a risk factor for poor outcome in the Idiopathic Intracranial Hypertension Treatment Trial.
Wall M; Thurtell MJ;
Br J Ophthalmol; 2017 Sep; 101(9):1256-1260. PubMed ID: 28130349
[TBL] [Abstract][Full Text] [Related]
8. Effects of lowering cerebrospinal fluid pressure on the shape of the peripapillary retina in intracranial hypertension.
Sibony P; Kupersmith MJ; Honkanen R; Rohlf FJ; Torab-Parhiz A
Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8223-31. PubMed ID: 25406288
[TBL] [Abstract][Full Text] [Related]
9. Retinal vessel diameter changes after 6 months of treatment in the Idiopathic Intracranial Hypertension Treatment Trial.
Moss HE; Hollar RA; Fischer WS; Feldon SE
Br J Ophthalmol; 2020 Oct; 104(10):1430-1434. PubMed ID: 31949093
[TBL] [Abstract][Full Text] [Related]
10. Shape analysis of the peripapillary RPE layer in papilledema and ischemic optic neuropathy.
Sibony P; Kupersmith MJ; Rohlf FJ
Invest Ophthalmol Vis Sci; 2011 Oct; 52(11):7987-95. PubMed ID: 21896851
[TBL] [Abstract][Full Text] [Related]
11. Optical coherence tomography for the diagnosis and monitoring of idiopathic intracranial hypertension.
Albrecht P; Blasberg C; Ringelstein M; Müller AK; Finis D; Guthoff R; Kadas EM; Lagreze W; Aktas O; Hartung HP; Paul F; Brandt AU; Methner A
J Neurol; 2017 Jul; 264(7):1370-1380. PubMed ID: 28584914
[TBL] [Abstract][Full Text] [Related]
12. Baseline OCT measurements in the idiopathic intracranial hypertension treatment trial, part II: correlations and relationship to clinical features.
; Auinger P; Durbin M; Feldon S; Garvin M; Kardon R; Keltner J; Kupersmith MJ; Sibony P; Plumb K; Wang JK; Werner JS
Invest Ophthalmol Vis Sci; 2014 Nov; 55(12):8173-9. PubMed ID: 25370513
[TBL] [Abstract][Full Text] [Related]
13. Visual Field Outcomes for the Idiopathic Intracranial Hypertension Treatment Trial (IIHTT).
Wall M; Johnson CA; Cello KE; Zamba KD; McDermott MP; Keltner JL;
Invest Ophthalmol Vis Sci; 2016 Mar; 57(3):805-12. PubMed ID: 26934136
[TBL] [Abstract][Full Text] [Related]
14. Optical coherence tomography of the optic nerve head detects acute changes in intracranial pressure.
Anand A; Pass A; Urfy MZ; Tang R; Cajavilca C; Calvillo E; Suarez JI; Venkatasubba Rao CP; Bershad EM
J Clin Neurosci; 2016 Jul; 29():73-6. PubMed ID: 26898579
[TBL] [Abstract][Full Text] [Related]
15. The Effect of Acetazolamide and Weight Loss on Intraocular Pressure in Idiopathic Intracranial Hypertension Patients.
Banik R; Kupersmith MJ; Wang JK; Garvin MK;
J Glaucoma; 2019 Apr; 28(4):352-356. PubMed ID: 30624392
[TBL] [Abstract][Full Text] [Related]
16. Acute Peripapillary Retinal Pigment Epithelium Changes Associated with Acute Intraocular Pressure Elevation.
Wang YX; Jiang R; Wang NL; Xu L; Jonas JB
Ophthalmology; 2015 Oct; 122(10):2022-8. PubMed ID: 26189187
[TBL] [Abstract][Full Text] [Related]
17. CSF pressure, papilledema grade, and response to acetazolamide in the Idiopathic Intracranial Hypertension Treatment Trial.
Kattah JC; Pula JH; Mejico LJ; McDermott MP; Kupersmith MJ; Wall M
J Neurol; 2015 Oct; 262(10):2271-4. PubMed ID: 26159101
[TBL] [Abstract][Full Text] [Related]
18. The Longitudinal Idiopathic Intracranial Hypertension Trial: Outcomes From Months 6-12.
Wall M; Kupersmith MJ; Thurtell MJ; Moss HE; Moss EA; Auinger P;
Am J Ophthalmol; 2017 Apr; 176():102-107. PubMed ID: 28104417
[TBL] [Abstract][Full Text] [Related]
19. Using Optical Coherence Tomography as a Surrogate of Measurements of Intracranial Pressure in Idiopathic Intracranial Hypertension.
Vijay V; Mollan SP; Mitchell JL; Bilton E; Alimajstorovic Z; Markey KA; Fong A; Walker JK; Lyons HS; Yiangou A; Tsermoulas G; Brock K; Sinclair AJ
JAMA Ophthalmol; 2020 Dec; 138(12):1264-1271. PubMed ID: 33090189
[TBL] [Abstract][Full Text] [Related]
20. OCT measurements of optic nerve head changes in idiopathic intracranial hypertension.
Huang-Link YM; Al-Hawasi A; Oberwahrenbrock T; Jin YP
Clin Neurol Neurosurg; 2015 Mar; 130():122-7. PubMed ID: 25614195
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
